President Biden has endorsed Vice President Harris, who has a more left-leaning approach to health care. Harris supports Medicare for All and drug pricing reforms, and is a strong advocate for reproductive rights. A new report from HSBC on health investment shows promising trends for the first half of 2024, with increased investments across all health sectors. Eli Lilly’s weight loss drug has won approval in China, competing with Novo Nordisk. Express Scripts overcharged U.S. Postal Service employees by $45 million for prescription drugs. Other news includes Google co-founder backing a biotech studying psychedelics and Siga signing a supply contract for an antiviral drug.
Source link
Kamala Harris health policy, Zepbound in China, etc
